An in-depth look to EXCELSIOR BIOPHARMA INC operating, investing, and financing activities

6496 free cash flow for Q3 24 is -58.19 M TWD. For 2023, 6496 free cash flow was -169 M TWD and operating cash flow was -133.34 M TWD.